First Time Loading...

Concert Pharmaceuticals Inc
NASDAQ:CNCE

Watchlist Manager
Concert Pharmaceuticals Inc Logo
Concert Pharmaceuticals Inc
NASDAQ:CNCE
Watchlist
Price: 8.37 USD Market Closed
Updated: May 10, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

171.1m
-3%
Assets
Growth Rates:
1 Year
+33%
3 Years
+13%
5 Years
-19%
7 Years
+17%
10 Years
-
37.9m
-22%
Liabilities
Growth Rates:
1 Year
+30%
3 Years
+16%
5 Years
+131%
7 Years
+118%
10 Years
-
133.3m
+4%
Equity
Growth Rates:
1 Year
+34%
3 Years
+12%
5 Years
-32%
7 Years
+3%
10 Years
-

Balance Sheet Decomposition
Concert Pharmaceuticals Inc

171.1m
Assets
37.9m
Liabilities
171.1m
Assets
37.9m
Liabilities
Current Assets 157.2m
Cash & Short-Term Investments 149.5m
Receivables 1.6m
Other Current Assets 6m
Non-Current Assets 13.9m
PP&E 12.8m
Other Non-Current Assets 1.2m
Current Liabilities 17.4m
Accounts Payable 2.7m
Accrued Liabilities 4.7m
Other Current Liabilities 9.9m
Non-Current Liabilities 20.5m
Other Non-Current Liabilities 20.5m

Balance Sheet
Concert Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021
Assets
Cash & Cash Equivalents
8
10
13
93
41
28
18
53
77
142
Cash
0
0
2
1
13
20
8
10
7
9
Cash Equivalents
8
10
12
92
27
8
9
43
70
133
Short-Term Investments
20
23
66
50
56
176
143
59
55
1
Total Receivables
0
0
1
0
0
1
17
0
3
0
Accounts Receivables
0
0
1
0
0
0
16
0
1
0
Other Receivables
0
0
0
0
0
1
1
0
3
0
Other Current Assets
1
1
1
2
1
2
3
5
8
7
Total Current Assets
29
34
82
144
98
206
180
117
143
150
PP&E Net
4
3
2
2
2
2
9
17
15
14
PP&E Gross
4
3
2
2
2
2
9
17
15
14
Accumulated Depreciation
5
6
6
6
7
7
2
3
4
4
Note Receivable
0
0
0
0
0
2
2
2
0
0
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
1
3
1
1
1
2
1
1
1
1
Total Assets
33
N/A
40
+20%
85
+112%
147
+74%
100
-32%
212
+111%
193
-9%
138
-29%
159
+16%
165
+4%
Liabilities
Accounts Payable
1
1
1
1
1
1
1
1
0
3
Accrued Liabilities
0
1
3
3
3
3
4
4
5
6
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
5
8
7
0
0
0
0
0
0
0
Other Current Liabilities
2
6
8
3
3
2
4
12
5
8
Total Current Liabilities
8
16
19
7
6
6
9
17
10
16
Long-Term Debt
16
7
0
0
0
0
0
0
0
0
Other Liabilities
5
16
11
10
9
9
16
19
18
37
Total Liabilities
28
N/A
40
+41%
30
-25%
16
-45%
15
-9%
15
+3%
25
+62%
36
+45%
28
-22%
53
+89%
Equity
Common Stock
112
112
0
0
0
0
0
0
0
0
Retained Earnings
108
114
145
121
172
76
117
195
269
349
Additional Paid In Capital
1
2
200
252
258
273
284
296
401
462
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
5
N/A
0
-98%
55
+54 700%
131
+138%
86
-34%
196
+129%
168
-15%
102
-39%
131
+29%
112
-14%
Total Liabilities & Equity
33
N/A
40
+20%
85
+112%
147
+74%
100
-32%
212
+111%
193
-9%
138
-29%
159
+16%
165
+4%
Shares Outstanding
Common Shares Outstanding
11
17
18
22
22
23
23
24
32
35
Preferred Shares Outstanding
0
56
0
0
0
0
0
0
0
0

See Also

Summary
CNCE intrinsic value, competitors valuation, and company profile.
DCF Valuation
CNCE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CNCE stock valuation using valuation multiples.
Wall Street Estimates
CNCE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CNCE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.